Article Name Acquisition/ Partnership
The acquisition also positions Catheter Precision to participate in the evolving advanced air mobility sector
21st April, 2026
Acquisition establishes Hexagon as a leading global provider of non-destructive testing (NDT) solutions, extending precision measurement from the surface to the inside of components and broadening Hexagon's footprint from the production floor into the maintenance, repair and operations (MRO) market
13th April, 2026
Expands OEM platform and strengthens leadership in nuclear medicine imaging
03rd April, 2026
These strengths enhance our platform and position us to meet the growing demand for high-quality teleradiology services in outpatient imaging
02nd April, 2026
Transaction strengthens Radon's service capabilities and expands its presence into Louisiana and Mississippi
01st April, 2026
The Company has acquired the rights to develop, manufacture, and commercialise CARDAMYST (etripamil) nasal spray in Greater China
24th March, 2026
As part of this strategic move, BPL Medical Technologies has launched BM Tech’s advanced bone mineral density measuring machines in India and Dubai
11th March, 2026
The JADA System for treatment of abnormal postpartum uterine bleeding, and the team behind the product, join Laborie, strengthening the company's commitment to improving maternal health
29th January, 2026
Parks Medical continues to be a trusted partner to healthcare professionals and organisations worldwide
29th January, 2026
The transaction positions Serres to build on its leading position in Europe
20th January, 2026
Builds an integrated global commercialisation platform to accelerate Zylox-Tonbridge's adoption of innovative vascular solutions worldwide
16th January, 2026
This strategic transaction marks a key milestone in the development of Affidea Switzerland
15th January, 2026
SHINE acquires Billerica manufacturing facility and establishes SPECT product portfolio, expanding leadership in nuclear medicine
05th January, 2026
Acquisition will also add an incremental 14 dispensaries to the Company’s retail footprint in Colorado
24th December, 2025
The partnership marks a significant step forward in promoting proactive food safety and environmental monitoring
22nd December, 2025
The combined businesses are expected to generate approximately €26 million in annual revenue
19th December, 2025
This acquisition complements IBA’s existing nuclear medicine strategic initiatives, including the co-founding of PanTera for the production of Ac-225, and the shaping of the Accelerate
19th December, 2025
The property also includes a 4.7-acre development site with municipal zoning for a retirement residence or residential condominium
18th December, 2025
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer